GLP-1 (glucagon-like peptide-1) discovered in the 1980s functions as a hormone derived from the proglucagon sequence and was found to have a transformative impact on the treatment of diabetes and ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

It is also a source of essential amino acids, substances that we cannot ... The active ingredient in the drug is glucagon-like peptides, which are increasingly being discussed in the context ...

The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, according to a ...

Objective—Glucagon-like peptide 1 (GLP-1) exerts beneficial antidiabetic actions via effects on pancreatic β- and α-cells. Previous studies have focused on the improvements in β-cell function ...

Tirzepatide (Mounjaro, Persovance, Zepbound) is a 39-amino-acid modified peptide based on the GIP sequence ... The drug candidate is a new biological entity (NBE) which acts by targeting glucagon like ...

With glucagon-like peptide 1 (GLP-1) agonists now close to inducing weight loss at levels only seen before through surgical intervention, obesity specialists say patients on these drugs are ...

Amino acids are concentrated in protein-rich foods such as meat ... of body weight, with a 2:1:1 ratio of leucine, isoleucine, and valine. Those who took the BCAAs showed improved performance ...

A study conducted by researchers at the Kennedy Institute of Rheumatology has uncovered a pivotal role of asparagine metabolism in regulating B cell homeostasis and immune response. Germinal ...

Adhesion G protein-coupled receptors (GPCRs) are a group of cell-surface sensors associated with many body functions and diseases. However, they are not yet sufficiently understood to be exploited for ...